WallStreetZenWallStreetZen

NASDAQ: PALI
Palisade Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PALI past revenue growth

How has PALI's revenue growth performed historically?
Company
N/A
Industry
69.21%
Market
13.96%
PALI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PALI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

PALI earnings and revenue history

Current Revenue
$250.0k
Current Earnings
-$12.4M
Current Profit Margin
-4,958%

PALI Return on Equity

Current Company
-115.7%
Current Industry
-17.9%
Current Market
30.8%
PALI's Return on Equity (-115.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PALI announces earnings.

PALI Return on Assets

Current Company
-90%
Current Industry
1%
PALI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PALI Return on Capital Employed

Current Company
-88.79%
Current Industry
14.2%
PALI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PALI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PALI$250.00k-$12.24M-$12.40M-0.78%N/A
ENVB$0.00-$19.66M-$19.08M-100.00%N/A
CYCN$914.00k-$38.41M-$38.05M-94.15%N/A
PTIX$0.00-$2.78M-$2.91MN/AN/A
AGLE$1.17M-$75.98M-$77.80M-27.29%N/A
View Top Biotech Stocks

Palisade Bio Earnings & Revenue FAQ

What were PALI's earnings last quarter?

On Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q1 2023 earnings per share (EPS) of -$0.54, up 95.83% year over year. Total Palisade Bio earnings for the quarter were -$2.34 million. In the same quarter last year, Palisade Bio's earnings per share (EPS) was -$12.96.

If you're new to stock investing, here's how to buy Palisade Bio stock.

What was PALI's earnings growth in the past year?

As of Q2 2023, Palisade Bio's earnings has grown year over year. Palisade Bio's earnings in the past year totalled -$12.40 million.

What was PALI's revenue last quarter?

On Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q1 2023 revenue of $250.00 thousand up Infinity% year over year. In the same quarter last year, Palisade Bio's revenue was $0.00.

What was PALI's revenue growth in the past year?

As of Q2 2023, Palisade Bio's revenue has grown null year over year. Palisade Bio's revenue in the past year totalled $250.00 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.